Table 3. Adjusted Hazard Ratios Between Area Deprivation Index, Medicare-Medicaid Dual Eligibility, and Mortalitya.
Breastb | P value | Prostatec | P value | Lung | P value | CRC | P value | |
---|---|---|---|---|---|---|---|---|
Overall mortality | ||||||||
ADI quintile | ||||||||
Q1 | 1 [Reference] | NA | 1 [Reference] | NA | 1 [Reference] | NA | 1 [Reference] | NA |
Q2 | 1.12 (1.04-1.20) | .002 | 1.11 (1.04-1.19) | .002 | 1.08 (1.03-1.14) | .003 | 1.16 (1.09-1.23) | <.001 |
Q3 | 1.19 (1.12-1.27) | <.001 | 1.28 (1.19-1.36) | <.001 | 1.10 (1.04-1.16) | .001 | 1.18 (1.12-1.26) | <.001 |
Q4 | 1.31 (1.23-1.40) | <.001 | 1.36 (1.27-1.45) | <.001 | 1.21 (1.15-1.28) | <.001 | 1.23 (1.16-1.31) | <.001 |
Q5 | 1.34 (1.26-1.43) | <.001 | 1.51 (1.42-1.62) | <.001 | 1.21 (1.14-1.28) | <.001 | 1.24 (1.17-1.32) | <.001 |
DE | ||||||||
No | 1 [Reference] | NA | 1 [Reference] | NA | 1 [Reference] | NA | 1 [Reference] | NA |
Yes | 1.22 (1.15-1.29) | <.001 | 1.29 (1.21-1.38) | <.001 | 1.14 (1.09-1.20) | <.001 | 1.23 (1.17-1.29) | <.001 |
Cancer-specific mortality | ||||||||
ADI quintile | ||||||||
Q1 | 1 [Reference] | NA | 1 [Reference] | NA | 1 [Reference] | NA | 1 [Reference] | NA |
Q2 | 1.20 (1.04-1.39) | .01 | 1.00 (0.82-1.22) | .98 | 1.05 (0.98-1.12) | .14 | 1.21 (1.09-1.33) | <.001 |
Q3 | 1.21 (1.05-1.40) | .008 | 1.22 (1.02-1.47) | .03 | 1.07 (1.00-1.14) | .04 | 1.27 (1.15-1.40) | <.001 |
Q4 | 1.31 (1.23-1.40) | <.001 | 1.36 (1.27-1.45) | <.001 | 1.21 (1.15-1.28) | <.001 | 1.23 (1.16-1.31) | <.001 |
Q5 | 1.50 (1.30-1.72) | <.001 | 1.38 (1.15-1.66) | <.001 | 1.16 (1.09-1.24) | <.001 | 1.33 (1.21-1.47) | <.001 |
DE | ||||||||
No | 1 [Reference] | NA | 1 [Reference] | NA | 1 [Reference] | NA | 1 [Reference] | NA |
Yes | 1.23 (1.10-1.37) | <.001 | 1.29 (1.07-1.55) | .007 | 1.14 (1.08-1.21) | <.001 | 1.29 (1.19-1.40) | <.001 |
Abbreviations: ADI, Area Deprivation Index; CRC, colorectal cancer; DE, Medicare-Medicaid dual eligibility; NA, not applicable; Q1, quintile 1; Q2, quintile 2; Q3, quintile 3; Q4, quintile 4; Q5, quintile 5.
Adjusted for age, sex, race and ethnicity, marital status, stage, Elixhauser comorbidity index, surgery, radiotherapy, and chemotherapy. Area Deprivation Index and DE were mutually adjusted.
For breast cancer, hormone receptor status was additionally adjusted.
For prostate cancer, androgen deprivation therapy was additionally adjusted.